Yide Hu

416 total citations
23 papers, 347 citations indexed

About

Yide Hu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yide Hu has authored 23 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yide Hu's work include Cancer-related Molecular Pathways (5 papers), Cancer Cells and Metastasis (3 papers) and Berberine and alkaloids research (2 papers). Yide Hu is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Cancer Cells and Metastasis (3 papers) and Berberine and alkaloids research (2 papers). Yide Hu collaborates with scholars based in China and United States. Yide Hu's co-authors include Yu Xu, Weiwei Yuan, Guanghui Li, Yu Xiao, Donglin Wang, Bo Zhu, Zhang Xue-lin, Shasha Li, Zhengtang Chen and Shiyong Wu and has published in prestigious journals such as PLoS ONE, International Journal of Radiation Oncology*Biology*Physics and Life Sciences.

In The Last Decade

Yide Hu

23 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yide Hu China 12 198 97 72 47 41 23 347
Selim Uzunoğlu Türkiye 15 228 1.2× 95 1.0× 79 1.1× 57 1.2× 21 0.5× 29 418
Guangjie Sui China 10 196 1.0× 108 1.1× 43 0.6× 53 1.1× 34 0.8× 18 419
Xueting Shao China 8 194 1.0× 100 1.0× 82 1.1× 29 0.6× 31 0.8× 14 443
Pihong Li China 12 243 1.2× 86 0.9× 107 1.5× 61 1.3× 26 0.6× 23 456
Ya-Jung Shih Taiwan 15 184 0.9× 137 1.4× 75 1.0× 28 0.6× 31 0.8× 19 481
Huanhu Zhang China 10 125 0.6× 74 0.8× 57 0.8× 52 1.1× 23 0.6× 26 310
Caiguo Ye China 11 233 1.2× 82 0.8× 142 2.0× 32 0.7× 40 1.0× 16 390
Valentin David France 5 220 1.1× 173 1.8× 125 1.7× 73 1.6× 24 0.6× 7 468
Ping Yin China 13 228 1.2× 80 0.8× 68 0.9× 35 0.7× 18 0.4× 29 481
Yuzhou Pang China 12 148 0.7× 50 0.5× 64 0.9× 40 0.9× 33 0.8× 24 411

Countries citing papers authored by Yide Hu

Since Specialization
Citations

This map shows the geographic impact of Yide Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yide Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yide Hu more than expected).

Fields of papers citing papers by Yide Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yide Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yide Hu. The network helps show where Yide Hu may publish in the future.

Co-authorship network of co-authors of Yide Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yide Hu. A scholar is included among the top collaborators of Yide Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yide Hu. Yide Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Luo, Yan, Hao Wu, Caihong Feng, et al.. (2017). “One-Pot” Fabrication of Highly Versatile and Biocompatible Poly(vinyl alcohol)-porphyrin-based Nanotheranostics. Theranostics. 7(16). 3901–3914. 25 indexed citations
3.
Liu, Wenying, Yu Xiao, Minghui Zhang, et al.. (2015). PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer. PLoS ONE. 10(8). e0128943–e0128943. 36 indexed citations
4.
Tang, Ying, Jingming Hou, Guanghui Li, et al.. (2014). ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines. Oncology Reports. 32(5). 2168–2174. 28 indexed citations
5.
Zhang, Minghui, Yide Hu, Yu Xu, et al.. (2013). Human mesenchymal stem cells enhance autophagy of lung carcinoma cells against apoptosis during serum deprivation. International Journal of Oncology. 42(4). 1390–1398. 18 indexed citations
6.
Luo, Yan, et al.. (2013). EtBr-induced selective degradation of mitochondria occurs via autophagy. Oncology Reports. 30(3). 1201–1208. 4 indexed citations
7.
Yuan, Weiwei, Zhang Xue-lin, Yu Xu, et al.. (2012). Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma. Molecular Carcinogenesis. 53(1). 49–57. 34 indexed citations
8.
Xu, Yu, Yide Hu, Jing Zhou, et al.. (2012). shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells. Oncology Reports. 28(2). 629–639. 5 indexed citations
9.
Fu, Hua, et al.. (2012). [Evaluation of gefitinib plus radiotherapy in non-small-cell lung cancer patients with brain metastases].. PubMed. 92(8). 524–7. 9 indexed citations
10.
Wen, Quan, Yide Hu, Fuyun Ji, & Guisheng Qian. (2011). Mitochondrial DNA alterations of peripheral lymphocytes in acute lymphoblastic leukemia patients undergoing total body irradiation therapy. Radiation Oncology. 6(1). 133–133. 17 indexed citations
11.
Wen, Quan, Yide Hu, Xi Zhang, Peiyan Kong, & Xinghua Chen. (2011). Gene expression signature of lymphocyte in acute lymphoblastic leukemia patients immediately after total body irradiation. Leukemia Research. 35(8). 1044–1051. 2 indexed citations
12.
Xu, Yu, et al.. (2010). Establishing a lung cancer stem cell culture using autologous intratumoral fibroblasts as feeder cells. Cell Biology International. 35(5). 509–517. 7 indexed citations
13.
Li, Guanghui, Yaping Zhang, Zhengtang Chen, et al.. (2010). Effects of Berberine Against Radiation-Induced Intestinal Injury in Mice. International Journal of Radiation Oncology*Biology*Physics. 77(5). 1536–1544. 18 indexed citations
14.
Li, Guanghui, Donglin Wang, Yide Hu, et al.. (2009). Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy. Medical Oncology. 27(3). 919–925. 44 indexed citations
15.
Hu, Huang, Yide Hu, Na Li, & Yong Zhu. (2009). Inhibition of Tumor Growth and Metastasis by Non–Small Cell Lung Cancer Cells Transfected With Cyclin D1–Targeted siRNA. Oligonucleotides. 19(2). 151–161. 20 indexed citations
16.
Xu, Yu & Yide Hu. (2009). Lung cancer stem cells research. Clues from ontogeny.. PubMed. 30(11). 1381–9. 3 indexed citations
17.
Sun, Jianguo, et al.. (2007). [Study on enhancing sensitivity of SPC-A1 cells to chemotherapy by Livin isoform-specific gene silencing].. PubMed. 10(6). 461–5. 2 indexed citations
18.
Xie, Qichao, Yide Hu, Lingli Wang, et al.. (2005). The co-transfection of p16INK4a and p14ARF genes into human lung cancer cell line A549 and the effects on cell growth and chemosensitivity. Colloids and Surfaces B Biointerfaces. 46(3). 188–196. 11 indexed citations
19.
Sun, Jianguo, Rongxia Liao, Zhengtang Chen, et al.. (2005). [Gene transfection of Livin isoforms into A549 cell line and its effect on cell growth and sensitivity to chemotherapy and radiotherapy].. PubMed. 28(12). 836–40. 8 indexed citations
20.
Liu, Shanlin, et al.. (2000). Roles of Se and NO in apoptosis of hepatoma cells. Life Sciences. 68(6). 603–610. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026